Table 1.
In vitro mapping results of the ribozyme-accessible sites in the p53 RNA
Reaction sites, nucleotide position* | Number of clones†
|
|
---|---|---|
p53 RNA‡ (in vitro transcribed) | Cellular RNA from MDA-MB-231 cells§ | |
+41 | 4 | 4 |
+65 | 2 | 2 |
+307 | — | 1 |
+332¶ | — | 1 |
+340¶ | 1 | 1 |
+384¶ | 6 | 5 |
+389¶ | — | 1 |
Nucleotide positions are indicated as the nucleotide numbers after the translation initiation site and presented for the accessible uridines identified from the mapping analyses.
The number of individual clones containing a given uridine at the splice.
A portion of p53 target RNA (nucleotides 1–432).
A human breast cancer cell line that overexpresses a mutant p53 mRNA (AGA to AAA at codon 280).
The p53 gene is frequently mutated in human tumors downstream of nucleotide 328 (1).